| scholarly article | Q13442814 |
| P50 | author | Carles Vilariño-Güell | Q24283836 |
| Zbigniew K Wszolek | Q64754704 | ||
| Alex Rajput | Q64855014 | ||
| Owen A. Ross | Q67167640 | ||
| Barbara Jasinska-Myga | Q83920460 | ||
| Tanis J Ferman | Q91521563 | ||
| Alexandra I Soto-Ortolaza | Q114336709 | ||
| Jennifer M Kachergus | Q114430207 | ||
| Dennis W. Dickson | Q30504740 | ||
| Matthew J. Farrer | Q37380292 | ||
| P2093 | author name string | Kenya Nishioka | |
| Sarah J Lincoln | |||
| Christopher A Robinson | |||
| Christian Wider | |||
| P2860 | cites work | Evolutionarily conserved elements in vertebrate, insect, worm, and yeast genomes | Q24534193 |
| alpha-Synuclein promoter confers susceptibility to Parkinson's disease. | Q54699461 | ||
| -Synuclein and Parkinson disease susceptibility | Q57983273 | ||
| Lrrk2 pathogenic substitutions in Parkinson's disease | Q57983291 | ||
| Evaluation of the γ-synuclein gene in German Parkinson's disease patients | Q60689238 | ||
| No pathogenic mutations in the beta-synuclein gene in Parkinson's disease. | Q64858749 | ||
| Diffuse Lewy body disease | Q64917946 | ||
| Lewy body disease with and without dementia: a clinicopathological study of 35 cases | Q68029418 | ||
| Beta-synuclein inhibits formation of alpha-synuclein protofibrils: a possible therapeutic strategy against Parkinson's disease | Q73196542 | ||
| Validation of the neuropathologic criteria of the third consortium for dementia with Lewy bodies for prospectively diagnosed cases | Q24653609 | ||
| Beta-synuclein gene alterations in dementia with Lewy bodies | Q24684579 | ||
| Mutation in the alpha-synuclein gene identified in families with Parkinson's disease | Q27860459 | ||
| Alpha-synuclein in Lewy bodies | Q27860680 | ||
| Developmental expression and biochemical characterization of Emu family members | Q28504556 | ||
| Genome-wide genotyping in Parkinson's disease and neurologically normal controls: first stage analysis and public release of data | Q28943545 | ||
| The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia | Q29547174 | ||
| Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease | Q29547175 | ||
| Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium | Q29614409 | ||
| Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders | Q29614754 | ||
| Widespread alterations of alpha-synuclein in multiple system atrophy | Q30444927 | ||
| Gamma-synucleinopathy: neurodegeneration associated with overexpression of the mouse protein | Q30487162 | ||
| Multiple regions of alpha-synuclein are associated with Parkinson's disease | Q31155710 | ||
| Improved accuracy of clinical diagnosis of Lewy body Parkinson's disease | Q33183045 | ||
| Relative frequencies of Alzheimer disease, Lewy body, vascular and frontotemporal dementia, and hippocampal sclerosis in the State of Florida Brain Bank | Q33445409 | ||
| Absence of mutation in the beta- and gamma-synuclein genes in familial autosomal dominant Parkinson's disease. | Q33853344 | ||
| A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other | Q33909759 | ||
| Alzheimer disease with amygdala Lewy bodies: a distinct form of alpha-synucleinopathy | Q33997481 | ||
| beta-Synuclein inhibits alpha-synuclein aggregation: a possible role as an anti-parkinsonian factor | Q34099593 | ||
| Beta-synuclein modulates alpha-synuclein neurotoxicity by reducing alpha-synuclein protein expression | Q34564479 | ||
| Multiple candidate gene analysis identifies alpha-synuclein as a susceptibility gene for sporadic Parkinson's disease | Q34565111 | ||
| Beta-synuclein gene variants and Parkinson's disease: a preliminary case-control study | Q35994987 | ||
| Genetics of Parkinson disease: paradigm shifts and future prospects. | Q36423921 | ||
| SNCA variants are associated with increased risk for multiple system atrophy | Q36460907 | ||
| Axon pathology in Parkinson's disease and Lewy body dementia hippocampus contains alpha-, beta-, and gamma-synuclein | Q36677512 | ||
| Diffuse Lewy body disease in Japan | Q37941288 | ||
| Phylemon: a suite of web tools for molecular evolution, phylogenetics and phylogenomics | Q42148193 | ||
| Diffuse type of Lewy body disease: progressive dementia with abundant cortical Lewy bodies and senile changes of varying degree--a new disease? | Q42445413 | ||
| Reply to: SNCA variants are associated with increased risk of multiple system atrophy | Q43067213 | ||
| The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years | Q44801054 | ||
| Mutations in the gene encoding human persyn are not associated with amyotrophic lateral sclerosis or familial Parkinson's disease | Q47918224 | ||
| P433 | issue | 8 | |
| P921 | main subject | Synuclein | Q24767155 |
| P304 | page(s) | 970-975 | |
| P577 | publication date | 2010-08-01 | |
| P1433 | published in | Archives of Neurology | Q15766672 |
| P1476 | title | Association of alpha-, beta-, and gamma-Synuclein with diffuse lewy body disease | |
| P478 | volume | 67 |
| Q60960028 | A Meta-Analysis of α-Synuclein Multiplication in Familial Parkinsonism |
| Q38121773 | Advances in the genetics of Parkinson disease |
| Q39117185 | An exome study of Parkinson's disease in Sardinia, a Mediterranean genetic isolate |
| Q42427291 | Analysis of Plasminogen Genetic Variants in Multiple Sclerosis Patients |
| Q64242757 | Biasing the native α-synuclein conformational ensemble towards compact states abolishes aggregation and neurotoxicity |
| Q35094391 | Bridging molecular genetics and biomarkers in lewy body and related disorders |
| Q43063576 | CD4⁺ but not CD8⁺ T cells revert the impaired emotional behavior of immunocompromised RAG-1-deficient mice |
| Q36618103 | Can we clinically diagnose dementia with Lewy bodies yet? |
| Q48366824 | Common genetic etiology between "multiple sclerosis-like" single-gene disorders and familial multiple sclerosis |
| Q35186314 | Comparative analysis of human tissue interactomes reveals factors leading to tissue-specific manifestation of hereditary diseases |
| Q38501488 | Dementia With Lew Body: Impacts of Surgery |
| Q34389030 | Evaluation of the role of SNCA variants in survival without neurological disease |
| Q58740519 | Exome sequencing study in patients with multiple sclerosis reveals variants associated with disease course |
| Q38594414 | Genetic susceptibility variants in parkinsonism |
| Q38310765 | Genetics and underlying pathology of dementia |
| Q41954719 | Mutations in PRKN and SNCA Genes Important for the Progress of Parkinson's Disease |
| Q42062219 | New α- and γ-synuclein immunopathological lesions in human brain |
| Q64236121 | Next Generation Sequencing Analysis in Early Onset Dementia Patients |
| Q36321837 | Possible alterations in β-Synuclein, the non-amyloidogenic homologue of α-Synuclein, during progression of sporadic α-synucleinopathies |
| Q34323256 | Selective pattern of motor system damage in gamma-synuclein transgenic mice mirrors the respective pathology in amyotrophic lateral sclerosis |
| Q27694711 | The Synaptic Function of α-Synuclein |
| Q38139561 | The function of α-synuclein |
| Q34074501 | The genetic contributions of SNCA and LRRK2 genes to Lewy Body pathology in Alzheimer's disease |
| Q34450376 | UPDATE ON DEMENTIA WITH LEWY BODIES. |
| Q44085138 | Zebrafish brain proteomics reveals central proteins involved in neurodegeneration |
| Q39841127 | α-synuclein genetic variability: A biomarker for dementia in Parkinson disease |
Search more.